Reporting of medication adherence in randomized controlled trials of pharmacological interventions for SARS-CoV-2: a cross-sectional analysis

C K Lee, A Otunla, Brennan, JK Aronson, D Nunan
doi: https://doi.org/10.1101/2022.10.30.22281709

Article Information

doi 
https://doi.org/10.1101/2022.10.30.22281709
History 
  • October 30, 2022.
Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.

Author Information

  1. C K Lee1,*,
  2. A Otunla2,
  3. Brennan3,
  4. JK Aronson1 and
  5. D Nunan1
  1. 1Centre for Evidence Based Medicine, Nuffield Department of Primary Care Health Sciences, University of Oxford
  2. 2School of Clinical Medicine, John Radcliffe Hospital, University of Oxford
  3. 3School of Clinical Medicine, University of Cambridge
  1. ↵*Corresponding author: Charlotte Lee, charlotte.lee1{at}doctors.org.uk
Back to top
Posted October 30, 2022.
Download PDF
Data/Code
Email
Reporting of medication adherence in randomized controlled trials of pharmacological interventions for SARS-CoV-2: a cross-sectional analysis
C K Lee, A Otunla, Brennan, JK Aronson, D Nunan
medRxiv 2022.10.30.22281709; doi: https://doi.org/10.1101/2022.10.30.22281709
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area